The invention provides novel biomarkers kits and methods of diagnosing prognosing and subtyping IBS. In one aspect the invention provides novel genomic biomarkers for diagnosing classifying providing a prognosis for and assigning therapy for IBS in a subject in need thereof. In another aspect the present invention provides novel algorithms for the diagnosis and prognosis of IBS.